Inhibition Of Crystal Growth Of Roflumilast

Patent No. EP3634380 (titled "Inhibition Of Crystal Growth Of Roflumilast") was filed by Arcutis on Jun 4, 2018. The application was issued on Jan 10, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSSep 20, 2024ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3634380

ARCUTIS
Application Number
EP18733481A
Filing Date
Jun 4, 2018
Status
Granted And Under Opposition
Dec 8, 2023
Publication Date
Jan 10, 2024